Evidence map›Paper›PMID 36895681›Full record

ArticleContemporary clinical trials communications2023

A supportive text message intervention for individuals living with endometriosis (EndoSMS): Randomized controlled pilot and feasibility trial.

Kerry A Sherman, Melissa J Pehlivan, Julie Redfern, Mike Armour, Blake Dear, Anna Singleton, Tanya Duckworth, Donna Ciccia, Michael Cooper, Alex Hawkey and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Contemporary clinical trials communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Kerry A ShermanCentre for Emotional Health, School of Psychological Sciences, Macquarie University, Sydney, Australia.
Melissa J PehlivanCentre for Emotional Health, School of Psychological Sciences, Macquarie University, Sydney, Australia.
Julie RedfernSchool of Health Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Mike ArmourTranslational Health Research Institute (THRI), Western Sydney University, Sydney, Australia.
Blake DearCentre for Emotional Health, School of Psychological Sciences, Macquarie University, Sydney, Australia.
Anna SingletonSchool of Health Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Tanya DuckworthSchool of Psychology, Faculty of Health and Medical Sciences, University of Adelaide, Australia.
Donna CicciaEndometriosis Australia, Sydney, Australia.
Michael CooperRoyal Prince Alfred Hospital, Sydney, Australia.
Alex HawkeyTranslational Health Research Institute (THRI), Western Sydney University, Sydney, Australia.
Kelly A ParryAustralian College of Physical Education, Sydney, Australia.
Esther GandhiCentre for Emotional Health, School of Psychological Sciences, Macquarie University, Sydney, Australia.
Macquarie University · AUThe University of Sydney · AUTranslational Research Institute · AUAustralian College of Physical Education · AURoyal Prince Alfred Hospital · AUThe University of Adelaide · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: As a high symptom burden chronic condition, endometriosis is associated with diminished quality of life (QoL) and psychological distress. The EndoSMS text message intervention was developed to inform and support individuals living with endometriosis. The primary aim of this study is to assess the acceptability, feasibility and preliminary efficacy of EndoSMS, to improve endometriosis-specific QoL and reduce psychological distress in a randomised controlled trial, compared with care as usual. We will additionally assess the impact of EndoSMS on self-efficacy for managing endometriosis. Methodology: A two-arm parallel pilot randomised controlled trial with waitlist control was conducted. Baseline assessments included QoL, psychological distress, self-efficacy, demographic and medical variables. Following baseline survey completion, participants were randomised to either the Intervention (EndoSMS: 3-months of text messaging) or Control condition. At 3-month follow-up, all participants completed an online survey reassessing outcomes, and Intervention participants provided quantitative and qualitative user feedback on EndoSMS. Results: Data collection commenced on 18 November 2021 and was completed on 30 March 2022. Descriptive statistics will be used to analyse feasibility and acceptability of the intervention. Preliminary efficacy analyses will be conducted using linear mixed models for QoL, psychological distress and self-efficacy outcomes. Subgroup analyses will also be conducted for typically underserved populations (e.g., rural/regional). Conclusion: This pilot will provide acceptability, feasibility and preliminary efficacy evidence for the impact of a supportive text messaging program for endometriosis. It will contribute to understanding how to optimally support individuals in living with and managing their endometriosis. Trial Registration: Australian New Zealand Clinical Trials Registry.

Indexed as

EndometriosisFeasibilityInterventionRandomised controlled trialText message

Identifiers

PMID36895681
PMCPMC9989515
OpenAlexW4321190492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.